Physician profile
Michael J Stumpf
NPI 1003015918
$22,291.18
in general payments reported to CMS, 2019-2025
22 companies · $19.35 in 2025
The $19.35 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $1,150 · 2021: $8,122 · 2022: $9,898 · 2023: $2,568 · 2025: $19.35.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521 · Travel and Lodging: $1,050 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.66 |
| Travel and Lodging | $1,050.46 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,329.41 | 2021-2023 | Da Vinci Surgical System |
| Smith+Nephew, INC. | $1,283.17 | 2019-2023 | Collagenase Santyl, Stravix, Grafix |
| Organogenesis INC. | $505.44 | 2019-2023 | Puraply |
| Aroa Biosurgery Incorporated | $489.92 | 2022-2023 | |
| Musculoskeletal Transplant Foundation INC. | $441.37 | 2020-2022 | |
| Integra Lifesciences Corporation | $369.18 | 2019-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Tela Bio, INC. | $179.00 | 2021-2022 | |
| Osiris Therapeutics INC. | $139.64 | 2019 | |
| Exeltis, USA INC. | $70.50 | 2021-2023 | Slynd |
| Kci USA, INC. | $62.47 | 2019-2020 | |
| Davol INC. | $55.14 | 2021-2023 | Phasix Mesh |
| Acell, INC. | $55.06 | 2019-2020 | |
| Ethicon US, LLC | $53.08 | 2020-2025 | Echelon; Endopath |
| Medtronic, INC. | $46.70 | 2022 | |
| Paratek Pharmaceuticals, INC. | $37.09 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acacia Pharma INC | $32.34 | 2021 | |
| Innocoll Pharmaceuticals Limited | $28.52 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.98 | 2022 | |
| Polynovo North America LLC | $23.69 | 2022 | |
| Hydrofera LLC | $23.21 | 2023 | Cutimed Sorbact |
| Takeda Pharmaceuticals U.S.A., INC. | $21.94 | 2023 | Gattex |
| Biotissue Holdings INC. | $20.33 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stumpf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.